Duchenne

sarepta building
Favicon Fierce Pharma

Sarepta CEO to retire, citing 'shocking and ironic twist of fate'

Ingram’s departure comes at a crossroads for Sarepta, as the unwavering conviction that defined his tenure faces major commercial uncertainty.
Angus Liu Feb 26, 2026 11:30am
Amazing landscapes of Appenzell with impressive rock formations and beautiful lakes

Dyne readies FDA push after DMD exon 51 med excels in trial

Dec 8, 2025 10:50am